{"id":2862,"date":"2021-12-01T14:52:58","date_gmt":"2021-12-01T05:52:58","guid":{"rendered":"https:\/\/global-www.5star.ne.jp\/invest\/?post_type=financial&p=2862"},"modified":"2022-12-28T10:51:13","modified_gmt":"2022-12-28T01:51:13","slug":"fy2020-3q","status":"publish","type":"page","link":"https:\/\/global.topcon.com\/invest\/library\/financial\/fy2020-3q\/","title":{"rendered":"FY2020 Q3 Presentation Q&A"},"content":{"rendered":"\n

FY2020 Q3 Presentation<\/h2>\n\n\n\n
Date<\/th>January 29, 2021<\/td><\/tr>
Presente<\/strong>r<\/th>Haruhiko Akiyama, Director and Senior Executive Officer, CFO<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Q&AFor PDF file, please refer to “presentation material (with script)” on the previous page.<\/span><\/h3>\n\n\n\n

Common subject matters<\/h4>\n\n\n\n
\n
    \n
  • \n

    \n Earnings forecast<\/span>\n : Plans for Q4 are slight decrease in sales YoY and weaker recovery in income compared to Q3. I understand\n that you are expecting some increase of expenses, but isn’t it difficult to expect a little more growth in the\n top line?\n <\/p>\n

    \n As the background of this full year plan, we assume the negative case scenario that the spread of the new\n coronavirus infection will be accelerated, especially in the countries where the lockdown continues such as\n the U.S and Europe. Eyecare Business had been significantly affected by COVID-19 in Q4 in the last FY and we\n hope not this will happen again. However, we take such possible risks into account and set the sales plan this\n time.\n <\/p>\n <\/li>\n

  • \n

    \n Earnings forecast:<\/span>\n Could you explain the main contributing factor of 1 billion yen which is improved in OP this time?\n <\/p>\n

    \n The fixed cost reduction exceeds the previous estimate by 0.7 billion yen in Q3 YTD, and sales volume and\n product mix will account for the remaining 0.3 billion yen in Q4.\n <\/p>\n <\/li>\n

  • \n

    \n Fixed cost reductions:<\/span>\n I understand that business travel expenses have been drastically reduced due to changes in the way people\n work. I would like to know if there are any major changes in the way of business and earnings structure due to\n COVID-19.\n <\/p>\n

    \n Activity-related expenses were significantly declined such as marketing expenses including travel, exhibition\n and advertising expenses. Based on our experience so far, we have found that a certain amount of business can\n be carried out without business trips as before. So, as for the outlook for the next fiscal year, we believe\n that we will be able to manage those activity-related expenses although it won’t be similar level as this\n fiscal year.\n <\/p>\n <\/li>\n

  • \n

    \n Fixed cost reductions:<\/span>\n Regarding fixed cost reduction of 4.5 billion yen, how can you divide it into transitory factors due to\n COVID-19 and others due to efficiency improvement which we can expect to continue in the next fiscal year and\n beyond?\n <\/p>\n

    \n Although we have not broken down into specific figures, out of the 4.5 billion yen, more than half are\n estimated to be expenses so to say “we wanted to use but we couldn’t” such as business trips, and exhibitions.\n In addition, we will tightly manage overall expense usages under recent harsh business environment.\n <\/p>\n <\/li>\n

  • \n

    \n Semiconductor shortage:<\/span>\n How would semiconductor shortage influence on your business?\n <\/p>\n

    \n Although almost all our products use semiconductors and\/or microcomputers, there is some impact on a small\n part of surveying business at present. We are doing our best not to make a negative impact in this fiscal\n year. If the supply-demand balance for semiconductors deteriorates further in the future, some risks may\n possibly actualize.\n <\/p>\n <\/li>\n <\/ul>\n<\/div>\n\n\n\n

    Positioning Company\/Smart Infrastructure Business<\/h4>\n\n\n\n
    \n